Cothera Bioscience
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $30M
Investors
- 8
About Cothera Bioscience
Established in 2018 and based in Hangzhou, China, Cothera Bioscience is a biotechnology company that specializes in the research and development of tumor targeting drugs. The company develops innovative tumor-targeting drugs, conducting research and clinical development to address unmet needs in oncology. The company generates revenue from licensing agreements, partnerships and the development of proprietary oncology drug candidates.
Who invested in Cothera Bioscience
8 investors across 2 rounds
See all investors in Cothera Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cothera Bioscience
Who invested in Cothera Bioscience?
Cothera Bioscience has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cothera Bioscience raised?
Cothera Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cothera Bioscience last raise money?
Cothera Bioscience's most recent round on record is a Series B, in Jan 2021.
What does Cothera Bioscience do?
Established in 2018 and based in Hangzhou, China, Cothera Bioscience is a biotechnology company that specializes in the research and development of tumor targeting drugs.
Where is Cothera Bioscience headquartered?
Cothera Bioscience is headquartered in Hangzhou, China.
Which VCs invest in companies like Cothera Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Cothera Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cothera Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.